Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
GLP-1 Analogues Market Key Takeaways In terms of revenue, the global GLP-1 analogues market was valued at USD 66.48 billion in 2025
Enquire Now Frequently Asked Questions GLP-1 Agonists Market Size is valued at USD 43.1 billion in 2024 and is predicted to reach USD 260.1 billion by the year 2034 GLP-1 Agonists Market is expected to grow at an 19.9% CAGR during the forecast period for 2025-2034
Medicare Part D now covers semaglutide for patients with a BMI over 27 and cardiovascular disease, expanding access nationwide
In contrast, certain other GLP-1 receptor agonists (liraglutide, semaglutide, dulaglutide) have demonstrated cardiovascular benefits in their respective outcomes trials
JAMA 309, 12411250
Closing nudge to consult If you've read this far, you're not asking for a sales pitch
